These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 9401764

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
    Ecke D, Hanck T, Tulapurkar ME, Schäfer R, Kassack M, Stricker R, Reiser G.
    Biochem J; 2008 Jan 01; 409(1):107-16. PubMed ID: 17824841
    [Abstract] [Full Text] [Related]

  • 24. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists.
    Grobben B, Claes P, Roymans D, Esmans EL, Van Onckelen H, Slegers H.
    Br J Pharmacol; 2000 May 01; 130(1):139-45. PubMed ID: 10781009
    [Abstract] [Full Text] [Related]

  • 25. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M, Dickenson JM.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):166-73. PubMed ID: 16820147
    [Abstract] [Full Text] [Related]

  • 26. P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
    Claes P, Grobben B, Van Kolen K, Roymans D, Slegers H.
    Br J Pharmacol; 2001 Sep 14; 134(2):402-8. PubMed ID: 11564659
    [Abstract] [Full Text] [Related]

  • 27. Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.
    Qi AD, Kennedy C, Harden TK, Nicholas RA.
    Br J Pharmacol; 2001 Jan 14; 132(1):318-26. PubMed ID: 11156592
    [Abstract] [Full Text] [Related]

  • 28. Pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS), a putative P2Y(1) receptor antagonist, blocks signaling at a site distal to the receptor in Madin-Darby canine kidney-D(1) cells.
    Shehnaz D, Torres B, Balboa MA, Insel PA.
    J Pharmacol Exp Ther; 2000 Jan 14; 292(1):346-50. PubMed ID: 10604969
    [Abstract] [Full Text] [Related]

  • 29. P2Y receptor expression on astrocytes in the nucleus accumbens of rats.
    Franke H, Krügel U, Grosche J, Heine C, Härtig W, Allgaier C, Illes P.
    Neuroscience; 2004 Jan 14; 127(2):431-41. PubMed ID: 15262333
    [Abstract] [Full Text] [Related]

  • 30. Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells.
    Tonazzini I, Trincavelli ML, Montali M, Martini C.
    J Neurosci Res; 2008 Oct 14; 86(13):2857-66. PubMed ID: 18500760
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I.
    Pharmacol Ther; 2006 Jun 14; 110(3):415-32. PubMed ID: 16257449
    [Abstract] [Full Text] [Related]

  • 32. Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells.
    May C, Weigl L, Karel A, Hohenegger M.
    Biochem Pharmacol; 2006 May 14; 71(10):1497-509. PubMed ID: 16533496
    [Abstract] [Full Text] [Related]

  • 33. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
    Schachter JB, Sromek SM, Nicholas RA, Harden TK.
    Neuropharmacology; 1997 Sep 14; 36(9):1181-7. PubMed ID: 9364473
    [Abstract] [Full Text] [Related]

  • 34. A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes.
    O'Grady SM, Elmquist E, Filtz TM, Nicholas RA, Harden TK.
    J Biol Chem; 1996 Nov 15; 271(46):29080-7. PubMed ID: 8910562
    [Abstract] [Full Text] [Related]

  • 35. Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors.
    Boyer JL, O'Tuel JW, Fischer B, Jacobson KA, Harden TK.
    Br J Pharmacol; 1995 Nov 15; 116(6):2611-6. PubMed ID: 8590978
    [Abstract] [Full Text] [Related]

  • 36. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.
    Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, Soga T, Matsushime H, Furuichi K.
    Mol Pharmacol; 2001 Sep 15; 60(3):432-9. PubMed ID: 11502873
    [Abstract] [Full Text] [Related]

  • 37. Calcium dependence of purinergic subtype P2Y₁ receptor modulation of C6 glioma cell migration.
    Jantaratnotai N, McLarnon JG.
    Neurosci Lett; 2011 Jun 22; 497(2):80-4. PubMed ID: 21540076
    [Abstract] [Full Text] [Related]

  • 38. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
    Ecke D, Tulapurkar ME, Nahum V, Fischer B, Reiser G.
    Br J Pharmacol; 2006 Oct 22; 149(4):416-23. PubMed ID: 16953187
    [Abstract] [Full Text] [Related]

  • 39. ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor.
    Gustafsson AJ, Muraro L, Dahlberg C, Migaud M, Chevallier O, Khanh HN, Krishnan K, Li N, Islam MS.
    Mol Cell Endocrinol; 2011 Feb 10; 333(1):8-19. PubMed ID: 21094205
    [Abstract] [Full Text] [Related]

  • 40. The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses.
    Li Q, Schachter JB, Harden TK, Nicholas RA.
    Biochem Biophys Res Commun; 1997 Jul 18; 236(2):455-60. PubMed ID: 9240460
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.